Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Obesity Drugs Face Tough Road To Approval Amid Fears Of Widespread Use

Related Content

Market Snapshot: Obesity Space Is ‘Not For The Faint of Heart’

Jun 01 2009

Will A CV Warning On Meridia Alter FDA Views On Obesity Drugs?

Nov 30 2009

FDA Will Soon Finalize Obesity Guidance, May Tackle CV Safety Separately

Apr 15 2009

Trouble On The Line: Zimulti Shareholder Suit Fueled By Executive Comments On Earnings Calls

Aug 03 2010

Arena Airs More Mixed Data For Late-Stage Obesity Drug Lorcaserin

Sep 28 2009

FDA Opioid REMS Proposal Leaves Advisory Panel Wanting More - i.e. Mandatory Training

Jul 23 2010

REMS For Obesity Drugs May Need More Specifics After Qnexa Advisory Panel

Jul 19 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window